2015 annual financial data

Tempest Therapeutics 2015 Net margin

Tempest Therapeutics 2015 net margin with verified reported values.

Direct answer

Net margin was -26,432.85%.

Operating income was -71,999,000 USD and net income was -73,219,000 USD.
Operating cash flow was -50,286,000 USD.

Get free Tempest Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
277,000 USD
Operating income
-71,999,000 USD
Net income
-73,219,000 USD
Operating cash flow
-50,286,000 USD